David Ross Smith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Ross Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Ross Smith. David Ross Smith is Corporate EVP, CFO & CAO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL) and Corporate Executive VP & CFO in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL).
Latest Insider Trading Transactions of David Ross Smith
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 144.67 | 3,305 | 478,134 | 6,609 | |
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 340.01 | 3,305 | 1,123,718 | 14,862 | 18.2 K to 14.9 K (-18.19 %) |
May 06 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 144.67 | 3,305 | 478,134 | 18,167 | 14.9 K to 18.2 K (+22.24 %) |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 109.34 | 3,845 | 420,412 | 3,846 | |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 330.00 | 3,845 | 1,268,850 | 14,862 | 18.7 K to 14.9 K (-20.55 %) |
Apr 26 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 109.34 | 3,845 | 420,412 | 18,707 | 14.9 K to 18.7 K (+25.87 %) |
Apr 16 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 320.00 | 2,000 | 640,000 | 14,862 | 16.9 K to 14.9 K (-11.86 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 282.98 | 289 | 81,781 | 16,862 | 17.2 K to 16.9 K (-1.69 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 283.59 | 272 | 77,136 | 17,031 | 17.3 K to 17 K (-1.57 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 289.55 | 247 | 71,519 | 17,303 | 17.6 K to 17.3 K (-1.41 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 292.37 | 1,149 | 335,937 | 0 | 1.1 K to 0 (-100.00 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 291.83 | 1,400 | 408,558 | 1,149 | 2.5 K to 1.1 K (-54.92 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 290.03 | 6,107 | 1,771,191 | 2,549 | 8.7 K to 2.5 K (-70.55 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 260.88 | 3,795 | 990,040 | 17,550 | 21.3 K to 17.6 K (-17.78 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 14,234 | 0 | 21,345 | 7.1 K to 21.3 K (+200.17 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 8,656 | 0 to 8.7 K |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 7,111 | 15.8 K to 7.1 K (-54.90 %) |
Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 144.67 | 3,304 | 477,990 | 9,914 | |
Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 216.82 | 1,007 | 218,334 | 20,767 | 21.8 K to 20.8 K (-4.62 %) |
Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 216.42 | 2,297 | 497,110 | 21,774 | 24.1 K to 21.8 K (-9.54 %) |
Aug 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 144.67 | 3,304 | 477,990 | 24,071 | 20.8 K to 24.1 K (+15.91 %) |
Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | A | 179.66 | 7,261 | 1,304,511 | 7,261 | |
Jun 02 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 2,176 | 0 | 20,767 | 18.6 K to 20.8 K (+11.70 %) |
May 08 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 150.00 | 1,884 | 282,600 | 18,591 | 20.5 K to 18.6 K (-9.20 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,188 | 308,656 | 0 | |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 164.20 | 738 | 121,176 | 20,475 | 21.2 K to 20.5 K (-3.48 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 163.38 | 657 | 107,339 | 21,213 | 21.9 K to 21.2 K (-3.00 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 162.27 | 1,027 | 166,654 | 21,870 | 22.9 K to 21.9 K (-4.49 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 161.58 | 898 | 145,095 | 22,897 | 23.8 K to 22.9 K (-3.77 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 160.45 | 868 | 139,271 | 23,795 | 24.7 K to 23.8 K (-3.52 %) |
Feb 27 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,188 | 308,656 | 24,663 | 20.5 K to 24.7 K (+20.45 %) |
Feb 26 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 162.46 | 379 | 61,572 | 20,475 | 20.9 K to 20.5 K (-1.82 %) |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 109.34 | 3,846 | 420,522 | 7,691 | |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 88.05 | 4,365 | 384,338 | 4,366 | |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 168.37 | 351 | 59,097 | 20,854 | 21.2 K to 20.9 K (-1.66 %) |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 167.49 | 985 | 164,982 | 21,205 | 22.2 K to 21.2 K (-4.44 %) |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 166.53 | 6,875 | 1,144,874 | 22,190 | 29.1 K to 22.2 K (-23.65 %) |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 109.34 | 3,846 | 420,522 | 29,065 | 25.2 K to 29.1 K (+15.25 %) |
Feb 25 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 88.05 | 4,365 | 384,338 | 25,219 | 20.9 K to 25.2 K (+20.93 %) |
Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 402 | 69,803 | 20,854 | 21.3 K to 20.9 K (-1.89 %) |
Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 378 | 65,636 | 21,256 | 21.6 K to 21.3 K (-1.75 %) |
Feb 24 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 173.64 | 344 | 59,732 | 21,634 | 22 K to 21.6 K (-1.57 %) |
Feb 13 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 170.29 | 4,500 | 766,319 | 21,978 | 26.5 K to 22 K (-17.00 %) |
Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 159.07 | 5,031 | 800,281 | 26,478 | 31.5 K to 26.5 K (-15.97 %) |
Feb 10 2020 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 13,431 | 0 | 31,509 | 18.1 K to 31.5 K (+74.29 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 76.12 | 1,249 | 95,074 | 0 | |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.32 | 3 | 394 | 18,078 | 18.1 K to 18.1 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.20 | 4 | 525 | 18,081 | 18.1 K to 18.1 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.19 | 208 | 27,288 | 18,085 | 18.3 K to 18.1 K (-1.14 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.12 | 4 | 524 | 18,293 | 18.3 K to 18.3 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.08 | 101 | 13,239 | 18,297 | 18.4 K to 18.3 K (-0.55 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.01 | 4 | 524 | 18,398 | 18.4 K to 18.4 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.01 | 4 | 524 | 18,402 | 18.4 K to 18.4 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 131.00 | 8 | 1,048 | 18,406 | 18.4 K to 18.4 K (-0.04 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.94 | 4 | 524 | 18,414 | 18.4 K to 18.4 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.91 | 107 | 14,007 | 18,418 | 18.5 K to 18.4 K (-0.58 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.91 | 8 | 1,047 | 18,525 | 18.5 K to 18.5 K (-0.04 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.84 | 4 | 523 | 18,533 | 18.5 K to 18.5 K (-0.02 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.79 | 9 | 1,177 | 18,537 | 18.5 K to 18.5 K (-0.05 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.64 | 105 | 13,717 | 18,546 | 18.7 K to 18.5 K (-0.56 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.51 | 116 | 15,139 | 18,651 | 18.8 K to 18.7 K (-0.62 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.44 | 109 | 14,218 | 18,767 | 18.9 K to 18.8 K (-0.58 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 130.32 | 114 | 14,856 | 18,876 | 19 K to 18.9 K (-0.60 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 129.67 | 123 | 15,949 | 18,990 | 19.1 K to 19 K (-0.64 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 129.04 | 119 | 15,356 | 19,113 | 19.2 K to 19.1 K (-0.62 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 128.85 | 95 | 12,241 | 19,232 | 19.3 K to 19.2 K (-0.49 %) |
Aug 13 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 76.12 | 1,249 | 95,074 | 19,327 | 18.1 K to 19.3 K (+6.91 %) |
Aug 12 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 132.60 | 337 | 44,686 | 18,078 | 18.4 K to 18.1 K (-1.83 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 76.67 | 2,158 | 165,454 | 0 | |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 142.04 | 158 | 22,442 | 18,415 | 18.6 K to 18.4 K (-0.85 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.95 | 100 | 14,195 | 18,573 | 18.7 K to 18.6 K (-0.54 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.92 | 100 | 14,192 | 18,673 | 18.8 K to 18.7 K (-0.53 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.91 | 100 | 14,191 | 18,773 | 18.9 K to 18.8 K (-0.53 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.77 | 100 | 14,177 | 18,873 | 19 K to 18.9 K (-0.53 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.58 | 100 | 14,158 | 18,973 | 19.1 K to 19 K (-0.52 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.54 | 100 | 14,154 | 19,073 | 19.2 K to 19.1 K (-0.52 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.41 | 100 | 14,141 | 19,173 | 19.3 K to 19.2 K (-0.52 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.16 | 100 | 14,116 | 19,273 | 19.4 K to 19.3 K (-0.52 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.98 | 100 | 14,098 | 19,373 | 19.5 K to 19.4 K (-0.51 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.90 | 110 | 15,499 | 19,473 | 19.6 K to 19.5 K (-0.56 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.80 | 90 | 12,672 | 19,583 | 19.7 K to 19.6 K (-0.46 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.73 | 100 | 14,073 | 19,673 | 19.8 K to 19.7 K (-0.51 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.71 | 100 | 14,071 | 19,773 | 19.9 K to 19.8 K (-0.50 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.54 | 100 | 14,054 | 19,873 | 20 K to 19.9 K (-0.50 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.52 | 100 | 14,052 | 19,973 | 20.1 K to 20 K (-0.50 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.50 | 100 | 14,050 | 20,073 | 20.2 K to 20.1 K (-0.50 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.35 | 100 | 14,035 | 20,173 | 20.3 K to 20.2 K (-0.49 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.33 | 100 | 14,033 | 20,273 | 20.4 K to 20.3 K (-0.49 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.28 | 100 | 14,028 | 20,373 | 20.5 K to 20.4 K (-0.49 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.04 | 100 | 14,004 | 20,473 | 20.6 K to 20.5 K (-0.49 %) |
Mar 01 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 76.67 | 2,158 | 165,454 | 20,573 | 18.4 K to 20.6 K (+11.72 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 140.57 | 218 | 30,644 | 18,415 | 18.6 K to 18.4 K (-1.17 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 143.84 | 100 | 14,384 | 18,633 | 18.7 K to 18.6 K (-0.53 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 143.67 | 100 | 14,367 | 18,733 | 18.8 K to 18.7 K (-0.53 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 143.14 | 70 | 10,020 | 18,833 | 18.9 K to 18.8 K (-0.37 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 143.10 | 100 | 14,310 | 18,903 | 19 K to 18.9 K (-0.53 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.98 | 100 | 14,198 | 19,003 | 19.1 K to 19 K (-0.52 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.73 | 100 | 14,173 | 19,103 | 19.2 K to 19.1 K (-0.52 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.35 | 200 | 28,270 | 19,203 | 19.4 K to 19.2 K (-1.03 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 141.34 | 100 | 14,134 | 19,403 | 19.5 K to 19.4 K (-0.51 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.78 | 100 | 14,078 | 19,503 | 19.6 K to 19.5 K (-0.51 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.60 | 100 | 14,060 | 19,603 | 19.7 K to 19.6 K (-0.51 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.50 | 100 | 14,050 | 19,703 | 19.8 K to 19.7 K (-0.50 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.42 | 100 | 14,042 | 19,803 | 19.9 K to 19.8 K (-0.50 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.39 | 117 | 16,426 | 19,903 | 20 K to 19.9 K (-0.58 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.35 | 100 | 14,035 | 20,020 | 20.1 K to 20 K (-0.50 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.33 | 100 | 14,033 | 20,120 | 20.2 K to 20.1 K (-0.49 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Option Exercise | M | 73.70 | 4,187 | 308,582 | 4,188 | |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.30 | 100 | 14,030 | 20,220 | 20.3 K to 20.2 K (-0.49 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.27 | 100 | 14,027 | 20,320 | 20.4 K to 20.3 K (-0.49 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.26 | 100 | 14,026 | 20,420 | 20.5 K to 20.4 K (-0.49 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.19 | 100 | 14,019 | 20,520 | 20.6 K to 20.5 K (-0.48 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.10 | 100 | 14,010 | 20,620 | 20.7 K to 20.6 K (-0.48 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 140.03 | 100 | 14,003 | 20,720 | 20.8 K to 20.7 K (-0.48 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.98 | 100 | 13,998 | 20,820 | 20.9 K to 20.8 K (-0.48 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.94 | 100 | 13,994 | 20,920 | 21 K to 20.9 K (-0.48 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.92 | 100 | 13,992 | 21,020 | 21.1 K to 21 K (-0.47 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.88 | 100 | 13,988 | 21,120 | 21.2 K to 21.1 K (-0.47 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.85 | 100 | 13,985 | 21,220 | 21.3 K to 21.2 K (-0.47 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.82 | 100 | 13,982 | 21,320 | 21.4 K to 21.3 K (-0.47 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.80 | 100 | 13,980 | 21,420 | 21.5 K to 21.4 K (-0.46 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.79 | 100 | 13,979 | 21,520 | 21.6 K to 21.5 K (-0.46 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.77 | 100 | 13,977 | 21,620 | 21.7 K to 21.6 K (-0.46 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.75 | 100 | 13,975 | 21,720 | 21.8 K to 21.7 K (-0.46 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.70 | 400 | 55,880 | 21,820 | 22.2 K to 21.8 K (-1.80 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.69 | 300 | 41,907 | 22,220 | 22.5 K to 22.2 K (-1.33 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.65 | 100 | 13,965 | 22,520 | 22.6 K to 22.5 K (-0.44 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.64 | 100 | 13,964 | 22,620 | 22.7 K to 22.6 K (-0.44 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.62 | 750 | 104,714 | 22,720 | 23.5 K to 22.7 K (-3.20 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.61 | 100 | 13,961 | 23,470 | 23.6 K to 23.5 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.59 | 100 | 13,959 | 23,570 | 23.7 K to 23.6 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.58 | 100 | 13,958 | 23,670 | 23.8 K to 23.7 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.57 | 100 | 13,957 | 23,770 | 23.9 K to 23.8 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.56 | 100 | 13,956 | 23,870 | 24 K to 23.9 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.51 | 100 | 13,951 | 23,970 | 24.1 K to 24 K (-0.42 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.46 | 100 | 13,946 | 24,070 | 24.2 K to 24.1 K (-0.41 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 139.32 | 100 | 13,932 | 24,170 | 24.3 K to 24.2 K (-0.41 %) |
Feb 28 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Buy | M | 73.70 | 4,187 | 308,582 | 24,270 | 20.1 K to 24.3 K (+20.85 %) |
Feb 26 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 145.31 | 379 | 55,072 | 20,083 | 20.5 K to 20.1 K (-1.85 %) |
Feb 26 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 146.05 | 100 | 14,605 | 20,462 | 20.6 K to 20.5 K (-0.49 %) |
Feb 26 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 146.01 | 200 | 29,202 | 20,562 | 20.8 K to 20.6 K (-0.96 %) |
Feb 26 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 146.00 | 300 | 43,800 | 20,762 | 21.1 K to 20.8 K (-1.42 %) |
Feb 26 2019 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 145.93 | 200 | 29,186 | 21,062 | 21.3 K to 21.1 K (-0.94 %) |